Prostate Cancer Research

Analysis

Prostate Cancer Research is a registered charity in England and Wales, based in London. It was registered in March 2014, 12 years ago. Its declared purposes cover education/training and the advancement of health or saving of lives, which this site groups under health and saving lives. Legally it is a charitable incorporated organisation (CIO). It says it makes grants to organisations, provides advocacy/advice/information and sponsors or undertakes research.

In the financial year ending March 2025, Prostate Cancer Research reported income of £5.2m and spending of £6.1m, spending 117% of what it took in. Across the 5 years on record, from March 2021 to March 2025, income grew from £1.1m to £5.2m (+369%), an average of +47% a year. The sharpest change came in the year to March 2022, when income rose by 143%. Over the whole period it spent 108% of the income it received.

Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, Prostate Cancer Research sits at the 97th percentile: it is larger than about 96% of them. Against every charity in England and Wales with reported income it ranks in the 98th percentile. Charities of a similar size with the same main cause include Catalyst Support Limited (£5.2m), CMZ Ltd (£5.2m) and Goal (International) (£5.2m).

In its latest detailed accounts, income came from donations and legacies 98% and charitable activities 1.2%. Gifts in wills alone brought in £1.3m. Charitable activities took 66% of spending and raising funds 32%. Grants to other organisations totalled £1.8m. Reserves of £971k would cover about 2 months of spending at that rate. It employed 35 people.